Skip to main content
Have a personal or library account? Click to login
Pharmacotherapy for Essential Hypertension: A Brief Review Cover

Pharmacotherapy for Essential Hypertension: A Brief Review

Open Access
|Dec 2022

Abstract

Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment. Among those who receive treatment, the majority remain undertreated and do not achieve their blood pressure goals. Therefore, new hypertension guidelines introduce more conscientious treatment strategies to maximize the probability of achieving the new strict blood pressure goals compared with the previous guidelines. Who should receive treatment for hypertension? Which antihypertensive medications have the strongest supporting data? Are generic and more affordable medications as effective as expensive brand medications? What are the different treatment strategies to maximize success in controlling blood pressure? Here, we briefly review pharmacotherapy for hypertension and provide answers to these questions as well as some other common questions regarding treatment of hypertension.

DOI: https://doi.org/10.14797/mdcvj.1175 | Journal eISSN: 1947-6108
Language: English
Page range: 5 - 16
Submitted on: Oct 19, 2022
Accepted on: Nov 14, 2022
Published on: Dec 6, 2022
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2022 Behnam Heidari, Eleonora Avenatti, Khurram Nasir, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.